REUTERS: Bellicum Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of the company's experimental cancer drug after three cases of brain disease linked to head trauma. Shares of the Houston-based drug developer fell 48 percent to US$5.26 in ...
- Commentary: The hidden dividends of a longer life
- WOULD YOU BUY THESE 52-WEEK LOWS LARGE-CAP BLUE-CHIP SINGAPORE STOCKS NOW?
- WOTC – Education policy
- WOTC – Is HDB flat a good investment?
- Creative Capital: The American socialite championing Singapore talent and women’s rights
- WOTC – Use of town council software
- WOTC – Dispute over Oxfam report